Genetic subtyping of DLBCL revealed that the co-occurrence of mutations in the MYD88 and CD79B genes defines a unique molecular subtype of DLBCLs, mostly termed MCD [20,21,22,23,24]. The gene discussed is CD79B; the disease is diffuse large B-cell lymphoma.